Keyphrases
Acinetobacter Baumannii (A. baumannii)
100%
Penicillin
100%
Cefepime
100%
Cephalosporins
100%
Heteroresistance
100%
Baumannii
83%
Population Analysis Profiles
50%
Outer Membrane Protein
33%
Pulsed-field Gel Electrophoresis
33%
Profile Curve
33%
Antibiotics
16%
Antimicrobial
16%
Two-peak
16%
Protein Profile
16%
Slow Growth
16%
Resistance Level
16%
Protein Analysis
16%
Circular Ring
16%
Susceptibility Testing
16%
Agar Plate
16%
Colony Morphology
16%
Nosocomial Infection
16%
Ampicillin-sulbactam
16%
Therapeutic Outcome
16%
Resistance Phenotypes
16%
Major Pathogens
16%
Mueller-Hinton Agar
16%
Serial Passage
16%
Inhibition Halo
16%
Ticarcillin-clavulanic Acid
16%
Monotypic
16%
Antibiotic-free
16%
Growth Rate Analysis
16%
Cefpirome
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter Baumannii
100%
Penicillin Derivative
100%
Cefepime
100%
Cephalosporin Derivative
100%
Pulsed-Field Gel Electrophoresis
33%
Outer Membrane Protein
33%
Infectious Agent
16%
Hospital Infection
16%
Antiinfective Agent
16%
Agar
16%
Protein Characterization
16%
Clavulanic Acid
16%
Sultamicillin
16%
Ticarcillin
16%
Cefpirome
16%
Biochemistry, Genetics and Molecular Biology
Acinetobacter Baumannii
100%
Cefepime
100%
Penicillin
100%
Heteroresistance
100%
Outer Membrane Protein
33%
Pulsed-Field Gel Electrophoresis
33%
Protein Characterization
16%
Infectious Agent
16%
Agar
16%
Ampicillin
16%
Epsilometer Test
16%
Cefpirome
16%
Sulbactam
16%
Ticarcillin
16%
Immunology and Microbiology
Acinetobacter Baumannii
100%
Penicillin
100%
Outer Membrane
66%
Infectious Agent
33%
Etest
33%
Agar Plate
33%
Mueller-Hinton Agar
33%